Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Jul-22 4:59 PM View:  | Vivo Opportunity, LLC Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 3,329,510 | $55.00 | $183,123,008.00 | (100%) 3.33M to 0 | |
| 01-Jul-22 4:44 PM View: | Sinclair Andrew Director | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 1,314,130 | $55.00 | $72,277,000.00 | (100%) 1.31M to 0 | |
| 01-Jul-22 4:38 PM View: | Allen Andrew R Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 1,650 | $55.00 | $90,750.00 | (100%) 1.65K to 0 | |
| 01-Jul-22 4:37 PM View: | Collard Craig A Director | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 13,500 | $55.00 | $742,500.00 | (100%) 13.5K to 0 | |
| 01-Jul-22 4:35 PM View: | Dilly Stephen George CEO and President Director | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 5,000 | $55.00 | $275,000.00 | (100%) 5.0K to 0 | |
| 01-Jul-22 4:50 PM View: | Orbimed Advisors LLC Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition Duplicate | 1,964,770 | $55.00 | $108,062,000.00 | (100%) 1.96M to 0 | |
| 01-Jul-22 4:43 PM View: | Klencke Barbara Chief Medical Officer | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 10,000 | $55.00 | $550,000.00 | (67%) 15.0K to 5.0K | |
| 01-Jul-22 4:46 PM View: | Ashiya Mona Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 1,964,770 | $55.00 | $108,062,000.00 | (100%) 1.96M to 0 | |
| 01-Jul-22 4:45 PM View: | Aggarwal Gaurav Director | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition | 2,735,850 | $55.00 | $150,472,000.00 | (100%) 2.74M to 0 | |
| 01-Jul-22 4:43 PM View: | Klencke Barbara Chief Medical Officer | Sierra Oncology, Inc. (SRRA) | 01-Jul-22 | Disposition Duplicate | 5,000 | $55.00 | $275,000.00 | (100%) 5.0K to 0 | |
| 29-Apr-22 7:07 PM View: | Longitude Capital Partners ... 10% Owner | Sierra Oncology, Inc. (SRRA) | 27-Apr-22 | Acquisition (other) | 16,030 | -- | -- | < 1% 2.14M to 2.16M | |
| 29-Apr-22 7:07 PM View: | Longitude Capital Partners ... 10% Owner | Sierra Oncology, Inc. (SRRA) | 27-Apr-22 | Disposition (other) | 2,139,770 | -- | -- | (99%) 2.16M to 16.03K | |
| 07-Apr-22 4:12 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 06-Apr-22 | Option Exercise | 6,347 | $12.05 | $76,481.40 | 100% 0 to 6.35K | |
| 07-Apr-22 4:12 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 06-Apr-22 | Planned Option Sale | 6,347 | $37.25 | $236,409.00 | (100%) 6.35K to 0 | |
| 07-Apr-22 4:12 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 05-Apr-22 | Option Exercise | 100 | $12.05 | $1,205.00 | 100% 0 to 100 | |
| 07-Apr-22 4:12 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 05-Apr-22 | Planned Option Sale | 100 | $37.09 | $3,709.00 | (100%) 100 to 0 | |
| 04-Apr-22 7:25 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Apr-22 | Planned Option Sale | 2,000 | $35.14 | $70,276.80 | (100%) 2.0K to 0 | |
| 04-Apr-22 7:25 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Apr-22 | Option Exercise | 2,000 | $13.04 | $26,080.00 | 100% 0 to 2.0K | |
| 22-Mar-22 4:15 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 18-Mar-22 | Option Exercise | 100 | $12.05 | $1,205.00 | 100% 0 to 100 | |
| 22-Mar-22 4:15 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 18-Mar-22 | Planned Option Sale | 100 | $37.05 | $3,705.00 | (100%) 100 to 0 | |
| 17-Mar-22 6:33 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 17-Mar-22 | Option Exercise | 3,453 | $12.05 | $41,608.70 | 100% 0 to 3.45K | |
| 17-Mar-22 6:33 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 17-Mar-22 | Planned Option Sale | 3,453 | $37.06 | $127,954.00 | (100%) 3.45K to 0 | |
| 04-Mar-22 4:12 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Mar-22 | Option Exercise | 2,000 | $13.04 | $26,080.00 | 100% 0 to 2.0K | |
| 04-Mar-22 4:12 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Mar-22 | Planned Option Sale | 2,000 | $30.60 | $61,196.20 | (100%) 2.0K to 0 | |
| 08-Feb-22 4:03 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 07-Feb-22 | Option Exercise | 10,000 | $12.05 | $120,500.00 | 100% 0 to 10.0K | |
| 08-Feb-22 4:03 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 07-Feb-22 | Planned Option Sale | 10,000 | $32.32 | $323,225.00 | (100%) 10.0K to 0 | |
| 04-Feb-22 4:08 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Feb-22 | Option Exercise | 2,000 | $13.04 | $26,080.00 | 100% 0 to 2.0K | |
| 04-Feb-22 4:08 PM View: | Thomson Mary Christina General Counsel, CCO & Sec'y | Sierra Oncology, Inc. (SRRA) | 04-Feb-22 | Planned Option Sale | 2,000 | $29.78 | $59,560.00 | (100%) 2.0K to 0 | |
| 02-Feb-22 9:25 PM View: | Longitude Capital Partners ... 10% Owner | Sierra Oncology, Inc. (SRRA) | 02-Feb-22 | Purchase Duplicate | 175,000 | $27.00 | $4,725,000.00 | 9% 1.96M to 2.14M | |
| 02-Feb-22 9:24 PM View: | Richardson Joshua Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 02-Feb-22 | Purchase | 175,000 | $27.00 | $4,725,000.00 | 9% 1.96M to 2.14M | |
| 01-Feb-22 5:00 PM View: | Abingworth Llp 10% Owner | Sierra Oncology, Inc. (SRRA) | 31-Jan-22 | Purchase | 150,000 | $27.00 | $4,050,000.00 | 13% 1.16M to 1.31M | |
| 01-Feb-22 5:04 PM View: | Sinclair Andrew Director | Sierra Oncology, Inc. (SRRA) | 31-Jan-22 | Purchase Duplicate | 150,000 | $27.00 | $4,050,000.00 | 13% 1.16M to 1.31M | |
| 31-Jan-22 6:47 PM View: | Aggarwal Gaurav Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 31-Jan-22 | Purchase | 800,000 | $27.00 | $21,600,000.00 | 41% 1.94M to 2.74M | |
| 31-Jan-22 9:30 PM View: | Vivo Opportunity, LLC 10% Owner | Sierra Oncology, Inc. (SRRA) | 31-Jan-22 | Purchase Duplicate | 800,000 | $27.00 | $21,600,000.00 | 32% 2.53M to 3.33M | |
| 01-Feb-22 5:00 PM View: | Abingworth Llp 10% Owner | Sierra Oncology, Inc. (SRRA) | 28-Jan-22 | Exercise (in-the money or at-the-money) | 287,471 | $13.20 | $3,794,620.00 | 33% 876.66K to 1.16M | |
| 01-Feb-22 5:04 PM View: | Sinclair Andrew Director | Sierra Oncology, Inc. (SRRA) | 28-Jan-22 | Exercise (in-the money or at-the-money) Duplicate | 287,471 | $13.20 | $3,794,620.00 | 33% 876.66K to 1.16M | |
| 28-Jan-22 8:12 PM View: | Vivo Opportunity, LLC 10% Owner | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Exercise (in-the money or at-the-money) | 612,437 | $13.20 | $8,084,170.00 | 32% 1.92M to 2.53M | |
| 28-Jan-22 4:39 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Option Exercise | 5,000 | $12.05 | $60,250.00 | 100% 0 to 5.0K | |
| 28-Jan-22 4:39 PM View: | Turner William D. Chief Reg & Tech Ops Officer | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Planned Option Sale | 5,000 | $27.05 | $135,250.00 | (100%) 5.0K to 0 | |
| 28-Jan-22 4:47 PM View: | Thomson Mary Christina General Counsel & Secretary | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Planned Option Sale | 2,000 | $29.00 | $58,000.00 | (100%) 2.0K to 0 | |
| 28-Jan-22 9:22 PM View: | Orbimed Advisors LLC Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Exercise (in-the money or at-the-money) | 487,450 | $13.20 | $6,434,340.00 | 33% 1.48M to 1.96M | |
| 28-Jan-22 4:47 PM View: | Thomson Mary Christina General Counsel & Secretary | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Option Exercise | 2,000 | $13.04 | $26,080.00 | 100% 0 to 2.0K | |
| 28-Jan-22 7:53 PM View: | Aggarwal Gaurav Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Exercise (in-the money or at-the-money) | 480,277 | $13.20 | $6,339,660.00 | 33% 1.46M to 1.94M | |
| 28-Jan-22 9:23 PM View: | Ashiya Mona Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 26-Jan-22 | Exercise (in-the money or at-the-money) Duplicate | 487,450 | $13.20 | $6,434,340.00 | 33% 1.48M to 1.96M | |
| 27-Jan-22 9:22 PM View: | Richardson Joshua Director 10% Owner | Sierra Oncology, Inc. (SRRA) | 25-Jan-22 | Exercise (in-the money or at-the-money) | 487,451 | $13.20 | $6,434,350.00 | 33% 1.48M to 1.96M | |
| 27-Jan-22 9:23 PM View: | Longitude Capital Partners ... 10% Owner | Sierra Oncology, Inc. (SRRA) | 25-Jan-22 | Exercise (in-the money or at-the-money) Duplicate | 487,451 | $13.20 | $6,434,350.00 | 33% 1.48M to 1.96M | |
| 24-Nov-21 7:07 PM View: | Collard Craig A Director | Sierra Oncology, Inc. (SRRA) | 24-Nov-21 | Market Purchase | 7,899 | $23.08 | $182,348.00 | 141% 5.6K to 13.5K | (< 1%) |
| 24-Nov-21 7:07 PM View: | Collard Craig A Director | Sierra Oncology, Inc. (SRRA) | 23-Nov-21 | Market Purchase | 5,601 | $22.94 | $128,515.00 | 100% 0 to 5.6K | < 1% |
| 20-May-21 6:59 PM View: | Dilly Stephen George CEO and President Director | Sierra Oncology, Inc. (SRRA) | 19-May-21 | Market Purchase | 5,000 | $17.83 | $89,150.00 | 100% 0 to 5.0K | 3% |
| 18-Aug-20 8:16 PM View: | Klencke Barbara Chief Development Officer | Sierra Oncology, Inc. (SRRA) | 18-Aug-20 | Market Purchase | 5,950 | $12.22 | $72,709.60 | 104% 5.72K to 11.68K | 51% |
